- Home
- SM vs CERT Comparison
SM vs CERT Comparison
Compare SM & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SM
- CERT
- Stock Information
- Founded
- SM 1908
- CERT 2008
- Country
- SM United States
- CERT United States
- Employees
- SM N/A
- CERT N/A
- Industry
- SM Oil & Gas Production
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- SM Energy
- CERT Technology
- Exchange
- SM Nasdaq
- CERT Nasdaq
- Market Cap
- SM 2.6B
- CERT 2.3B
- IPO Year
- SM 1992
- CERT 2020
- Fundamental
- Price
- SM $23.63
- CERT $11.36
- Analyst Decision
- SM Buy
- CERT Buy
- Analyst Count
- SM 11
- CERT 6
- Target Price
- SM $42.00
- CERT $15.60
- AVG Volume (30 Days)
- SM 2.5M
- CERT 1.7M
- Earning Date
- SM 05-01-2025
- CERT 05-05-2025
- Dividend Yield
- SM 3.42%
- CERT N/A
- EPS Growth
- SM 11.97
- CERT N/A
- EPS
- SM 7.14
- CERT N/A
- Revenue
- SM $2,847,233,000.00
- CERT $394,498,000.00
- Revenue This Year
- SM $31.30
- CERT $11.47
- Revenue Next Year
- SM $0.50
- CERT $9.03
- P/E Ratio
- SM $3.28
- CERT N/A
- Revenue Growth
- SM 24.88
- CERT 9.37
- 52 Week Low
- SM $19.67
- CERT $8.64
- 52 Week High
- SM $50.77
- CERT $17.76
- Technical
- Relative Strength Index (RSI)
- SM 45.14
- CERT 41.96
- Support Level
- SM $22.33
- CERT $11.17
- Resistance Level
- SM $24.34
- CERT $11.75
- Average True Range (ATR)
- SM 0.77
- CERT 0.42
- MACD
- SM 0.07
- CERT -0.06
- Stochastic Oscillator
- SM 20.78
- CERT 24.00
About SM SM Energy Company
SM Energy Co is an independent energy company engaged in the acquisition, exploration, development, and production of oil, gas, and NGLs in Texas and Utah. Its portfolio is comprised of assets in the Midland Basin of West Texas, the Maverick Basin of South Texas, and the Uinta Basin of northeastern Utah.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.